Trump Claims Tylenol Linked to Autism; Massachusetts Parents Push Back
UPDATE: President Donald Trump has sparked controversy after announcing that the Food and Drug Administration believes the use of acetaminophen, the active ingredient in Tylenol, may be linked to an increased risk of autism when taken during pregnancy. This claim has ignited immediate backlash from parents and medical professionals across Massachusetts and beyond.
In a statement made on July 10, 2023, Trump promoted unproven correlations between acetaminophen, vaccines, and autism, leading many to express their frustration. Marlene Schlesinger, a mother from Newton, passionately defended her son, who thrives with autism. “It’s really frustrating. Being pregnant is hard enough, and hearing this could be what caused your child to be autistic is really hard, and not true,” she stated, highlighting the emotional toll such claims can have on parents.
Schlesinger, who leads “Nurturing Neurodivergence Together” support groups, took acetaminophen during both her pregnancies. She expressed outrage at Trump’s comments, emphasizing that they do not reflect the reality of her experience or the experiences of many families.
Kenvue, the manufacturer of Tylenol, quickly responded, firmly stating, “taking acetaminophen does not cause autism. We strongly disagree with any suggestion otherwise, and are deeply concerned about the health risks this poses for expecting mothers.” This statement underscores the ongoing debate surrounding the safety of medications during pregnancy.
Medical experts are also weighing in. Dr. Celine Gounder, a CBS News medical contributor, reassured the public that Tylenol is considered safe during pregnancy. “If you have a high fever during pregnancy, that can cause neurodevelopment issues in the baby, so you don’t want to let that fever go untreated,” Dr. Gounder explained, emphasizing the importance of managing health conditions effectively.
Advocates for autism awareness are calling for clarity and support in light of Trump’s statements. Maura Sullivan, CEO of the Arc of Massachusetts, noted that while she never used Tylenol during her pregnancies, her two sons are on the autism spectrum. She stressed the need for clear guidance, stating, “We just need the supports and accommodations to live safely and with inclusion within our community.” Sullivan’s remarks highlight the urgent need for comprehensive support for families affected by autism.
The announcement has ignited discussions about the need for further research and funding for autism studies. Sullivan acknowledged recent developments, such as the introduction of leucovorin as a potential treatment for some autism symptoms, as positive steps forward but emphasized the importance of continued advocacy for research funding from the National Institute of Health.
As the conversation unfolds, parents and advocates are urging the public to focus on facts and evidence-based guidance rather than unverified claims. The emotional impact of these statements cannot be understated, as many families navigate the complexities of raising children on the autism spectrum.
Experts and advocates alike will continue to monitor the situation closely, seeking to clarify the facts surrounding acetaminophen use and autism. The urgency for accurate information has never been more critical, as families strive for understanding and support in a challenging landscape.
Stay tuned for further updates on this developing story.
